The non-randomized, open label, uncontrolled, single group assignment, study will collect 9 month safety and efficacy data on the Assurant Cobalt Iliac Stent for all patients enrolled into the study. The estimated enrollment is 123 subjects. The study Principal Investigators are Robert G Monar, MD from Michigan Vascular Research Center and William Gray, MD from NY Presbyterian Hospital.